| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A bone paradigm challenging the standard model of myeloma oncogenesis
|
Capp, Jean-Pascal
|
|
|
172 |
C |
p.
|
artikel
|
| 2 |
Adjuvant chemotherapy after neoadjuvant chemo-radiotherapy and surgery in locally advanced rectal cancer. A systematic review of literature with a meta-analysis of randomized clinical trials
|
Tamburini, Emiliano
|
|
|
172 |
C |
p.
|
artikel
|
| 3 |
Advantages and drawbacks of dexamethasone in glioblastoma multiforme
|
Afshari, Amir R.
|
|
|
172 |
C |
p.
|
artikel
|
| 4 |
A meta-analysis of palifermin efficacy for the management of oral mucositis in patients with solid tumours and haematological malignancy
|
Coutsouvelis, John
|
|
|
172 |
C |
p.
|
artikel
|
| 5 |
A systematic review and meta-analysis of adjuvant chemotherapy after chemoradiation for locally advanced cervical cancer
|
Horeweg, Nanda
|
|
|
172 |
C |
p.
|
artikel
|
| 6 |
A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma
|
Tagliamento, Marco
|
|
|
172 |
C |
p.
|
artikel
|
| 7 |
BRAF-mutated colorectal adenocarcinomas: Pathological heterogeneity and clinical implications
|
Angerilli, Valentina
|
|
|
172 |
C |
p.
|
artikel
|
| 8 |
BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning
|
Fanale, Daniele
|
|
|
172 |
C |
p.
|
artikel
|
| 9 |
Can inflammasomes promote the pathophysiology of glioblastoma multiforme? A view about the potential of the anti-inflammasome therapy as pharmacological target
|
Rolim, Giovanna Barros
|
|
|
172 |
C |
p.
|
artikel
|
| 10 |
Editorial Board
|
|
|
|
172 |
C |
p.
|
artikel
|
| 11 |
Inadequate health-related quality of life assessment and reporting in phase III clinical trials of immune checkpoint inhibitors in solid cancers: A systematic review
|
Servetto, Alberto
|
|
|
172 |
C |
p.
|
artikel
|
| 12 |
Low-risk triple-negative breast cancers: Clinico-pathological and molecular features
|
Fusco, Nicola
|
|
|
172 |
C |
p.
|
artikel
|
| 13 |
Management of infectious risk of daratumumab therapy in multiple myeloma: A consensus-based position paper from an ad hoc Italian expert panel
|
Girmenia, Corrado
|
|
|
172 |
C |
p.
|
artikel
|
| 14 |
Medical oncological treatment for patients with Gastrointestinal Stromal Tumor (GIST) – A systematic review
|
Brinch, Charlotte Margareta
|
|
|
172 |
C |
p.
|
artikel
|
| 15 |
New advances in exosome-based targeted drug delivery systems
|
Ferreira, Débora
|
|
|
172 |
C |
p.
|
artikel
|
| 16 |
Pancreatic neuroendocrine neoplasms: Updates on genomic changes in inherited tumour syndromes and sporadic tumours based on WHO classification
|
Ishida, Hirotaka
|
|
|
172 |
C |
p.
|
artikel
|
| 17 |
Real-world insights into the efficacy and safety of tyrosine kinase inhibitors against thyroid cancers
|
Li, Lingyu
|
|
|
172 |
C |
p.
|
artikel
|
| 18 |
The expanding family of c-Met inhibitors in solid tumors: a comparative analysis of their pharmacologic and clinical differences
|
Fogli, Stefano
|
|
|
172 |
C |
p.
|
artikel
|
| 19 |
The long-term prognosis of patients with untreated primary uveal melanoma: A systematic review and meta-analysis
|
Stålhammar, Gustav
|
|
|
172 |
C |
p.
|
artikel
|
| 20 |
Underrepresentation of Black participants and adverse events in clinical trials of lenalidomide for myeloma
|
Milrod, Charles J.
|
|
|
172 |
C |
p.
|
artikel
|
Tijdschrift beschrijving